Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear friends, CBS2022 is in full swing now, and we are looking forward to welcoming in-person and on-line attendees Here are some brief highlights 1...

Canadian Biomaterials Society s Toronto Student Chapter is proud to present our Inaugural Biomaterials Symposium, a one-day event taking place on Tuesday, March 29th Join us online to learn and network with speakers across three universities in the GTA, as well as representatives from biomedical start-ups in the city...

SAVE THE DATE BIOMATERIALS AND REGENERATIVE MEDICINE BRMC 2022 Date March 21st and 22nd, 2022 Time 10 am to 4 pm Place Virtual through Zoom Register here https www...

CBS-ASC would like to invite you to the first webinar of 2022 that will be held on Thursday, March 3rd, 2022, at 4 pm MST via ZOOM on the topic titled Diversify your career options outside of academia ...

Leading edge regenerative therapies targeting heart failure have utilized the delivery of cardiac progenitor cells to improve heart function...

Ischemic heart disease IHD remains a leading cause of mortality1. After myocardial infarction MI fibrosis predominates tissue remodeling, resulting in impaired pump function and heart failure2,3...

objective using the delignification technology to deal with light wood, again USES the dopamine glue method combined with different concentrations of lysozyme, the preparation of light wood - lysozyme natural anti-infection dressings, and study the in vitro antibacterial activity and the effects on wound healing...

Vascular tissue engineering seeks to produce biologically and mechanically responsive vascular substitutes using cells, scaffolds and bioreactors, to address the shortcomings of current vascular interventions such as coronary artery bypass grafts and to create pre-clinical testing platforms to study vascular pathologies...

Tissue engineering is an important field that has allowed for the engineering of functional tissues in vitro and subsequent transplantation in vivo as a clinical strategy...